Endonovo Therapeutics Inc (PK) ENDV Income Statements

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
USOTC
Endonovo Therapeutics Inc (PK) (ENDV)
Endonovo Therapeutics Inc (PK) (ENDV) Financials

Endonovo Therapeutics Inc (PK) (ENDV)

0.0007

-0.0001

(-12.50%)

Closed November 29 3:00PM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	0	83k	310k	166k	73k	135k	140k
Operating Income	-4.6M	-4.16M	-3.81M	-2.91M	-2.23M	-3.27M	-2.92M
Pre Tax Income	-10.81M	-6.44M	-17.32M	-396k	-3.11M	-18.48M	6.93M
Net Income	-10.81M	-6.44M	-17.32M	-396k	-3.11M	-18.48M	6.93M
Preferred Dividends	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	-0.034	-0.015	-14.563	-0.023	-0.042	-0.095	0.022
EBIT	-2.04M	-3.84M	-3.74M	-3.36M	-2.23M	-3.49M	-2.95M
EBITDA	-4.59M	-3.51M	-3.16M	-2.26M	-1.58M	-2.62M	-2.27M

Endonovo Therapeutics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions